Bluejay Therapeutics
bluejaytx.comLocations
San Francisco, CA, USA
industry
Biotechnology
Size
11 - 50 employees
Stage
Series C+
founded in
2020
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global rights to advance several HBV programs, including a best-in-class anti-HBsAg monoclonal antibody.
Something looks off?Open jobs at Bluejay Therapeutics
On-site & Remote
Job function
Seniority
Salary